Search research articles
Contact Us
Filters
Showing results (21-30 of 782) with videos related to
Page
of 79
Sort By:
American Journal of Preventive Cardiology
|
July 3, 2026
LDL-cholesterol lowering: timing is everything
Alexander C Razavi, Roger S Blumenthal
Journal of the American College of Cardiology
|
March 14, 2009
Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study
Erin D Michos, Roger S Blumenthal
JAMA
|
October 22, 2009
Lipoprotein(a) measurement and determining risk of myocardial infarction
Steven R Jones, Roger S Blumenthal
The New England Journal of Medicine
|
November 17, 2009
The HALTS trial--halting atherosclerosis or halted too early?
Roger S Blumenthal, Erin D Michos
The American Journal of Cardiology
|
April 2, 2003
Usefulness of non-high-density lipoprotein cholesterol determinations in the diagnosis and treatment of dyslipidemia
Glenn A Hirsch, Roger S Blumenthal
Circulation
|
March 9, 2012
How accurate are 3 risk prediction models in US women?
Erin D Michos, Roger S Blumenthal
JAMA
|
March 15, 2006
Can a potent statin actually regress coronary atherosclerosis?
Roger S Blumenthal, Navin K Kapur
Nature Reviews. Cardiology
|
January 15, 2014
Risk factors: new risk-assessment guidelines-more or less personalized?
Michael J Blaha, Roger S Blumenthal
The New England Journal of Medicine
|
August 31, 2024
Prevention of Cardiovascular Disease - Don't Stop Thinking about Tomorrow
Roger S Blumenthal, Seth S Martin
Journal of the American College of Cardiology
|
March 13, 2026
Clinical Guidelines as a Continuous Work in Progress: Moving at the Speed of Science
Roger S Blumenthal, Pamela B Morris,
Page
of 79
Search research articles
Search
Showing results (21-30 of 782) with videos related to
Sort By:
Page
of 79
American Journal of Preventive Cardiology
|
July 3, 2026
LDL-cholesterol lowering: timing is everything
Alexander C Razavi, Roger S Blumenthal
Journal of the American College of Cardiology
|
March 14, 2009
Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study
Erin D Michos, Roger S Blumenthal
JAMA
|
October 22, 2009
Lipoprotein(a) measurement and determining risk of myocardial infarction
Steven R Jones, Roger S Blumenthal
The New England Journal of Medicine
|
November 17, 2009
The HALTS trial--halting atherosclerosis or halted too early?
Roger S Blumenthal, Erin D Michos
The American Journal of Cardiology
|
April 2, 2003
Usefulness of non-high-density lipoprotein cholesterol determinations in the diagnosis and treatment of dyslipidemia
Glenn A Hirsch, Roger S Blumenthal
Circulation
|
March 9, 2012
How accurate are 3 risk prediction models in US women?
Erin D Michos, Roger S Blumenthal
JAMA
|
March 15, 2006
Can a potent statin actually regress coronary atherosclerosis?
Roger S Blumenthal, Navin K Kapur
Nature Reviews. Cardiology
|
January 15, 2014
Risk factors: new risk-assessment guidelines-more or less personalized?
Michael J Blaha, Roger S Blumenthal
The New England Journal of Medicine
|
August 31, 2024
Prevention of Cardiovascular Disease - Don't Stop Thinking about Tomorrow
Roger S Blumenthal, Seth S Martin
Journal of the American College of Cardiology
|
March 13, 2026
Clinical Guidelines as a Continuous Work in Progress: Moving at the Speed of Science
Roger S Blumenthal, Pamela B Morris,
Page
of 79